Metastatic disease can occur in 12% of pediatric patients, in general, but may be up to 70% among SDHB mutation carriers, the second most commonly mutated gene in pediatric PPGL after VHL (19, 22, 23). The gene discussed is SDHB; the disease is metastatic neoplasm.